Last checked at 17 May 2005 07:00
Alliance Pharma PLC17 May 2005 For Immediate Release 17 May 2005 Alliance Pharma Plc Notification of Major Interests in Shares On 11 May 2005, the company was notified by RAB Capital that they have aninterest in 13,018,399 shares of the company, representing 8.83% of the issuedshare capital. RAB Capital does not act as custodian for its clients and therefore the sharesare held in the nominee name of the custodian of its clients, which are CSFBNominees Ltd and Morgan Stanley & Co. International Ltd. -ENDS- For further information: Alliance Pharma plc + 44 (0) 1249 466966 John Dawson, Chief ExecutiveMaddy Scott, Finance Directorwww.alliancepharma.co.uk Buchanan Communications + 44 (0) 20 7466 5000 Mark Court/Lisa Baderoon/Rebecca Skye Dietrich This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Alliance Pharma Regulatory News (APH)
APH Share
Price
APH Share
News
APH Share
Chat
APH Share
Trades240
APH
Live RNS
APH Share
Charts
APH Level 2
Console
APH Live
Share Price
APH Broker
Ratings
APH Directors
Deals
APH Financial
Diary
APH
Fundamentals
APH Short
Positions1
APH
Media
Alliance Pharma Information
Share Price Information for Alliance Pharma (APH)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
41.60
Bid:
41.55
Ask:
41.80
Change:
-0.30 (-0.72%)
Spread:
0.25 (0.602%)
Open:
43.00
High:
43.00
Low:
41.25
Prev. Close:
41.90
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Share Purchase
| Date | Source | Headline | |
|---|---|---|---|
| 11th Oct 2005 | 11:21 am | RNS | Results Notification |
| 30th Sep 2005 | 7:03 am | RNS | Misoprostol Symposium |
| 19th Sep 2005 | 7:02 am | RNS | Appointment |
| 1st Aug 2005 | 7:00 am | RNS | Notification of Shares |
| 29th Jul 2005 | 7:00 am | RNS | Distribution Agreement |
| 13th Jul 2005 | 10:11 am | RNS | Notification of Shares |
| 6th Jul 2005 | 7:00 am | RNS | Phase III Trials Approval |
| 24th Jun 2005 | 7:00 am | RNS | Notice of Interests in Shares |
| 21st Jun 2005 | 10:52 am | RNS | AGM Statement |
| 17th May 2005 | 7:00 am | RNS | Share Purchase |
| 16th May 2005 | 12:35 pm | RNS | Director Share Dealing |
| 12th May 2005 | 7:01 am | RNS | Preliminary Results |
| 11th May 2005 | 9:55 am | RNS | Share Purchase |
| 9th May 2005 | 7:00 am | RNS | Co-Promotion Agreement |
| 26th Apr 2005 | 7:02 am | RNS | Key Management Appointments |
| 30th Mar 2005 | 5:33 pm | RNS | Holding(s) in Company |
| 16th Mar 2005 | 7:00 am | RNS | Trading Statement |
| 28th Feb 2005 | 11:37 am | RNS | Director Shareholding |
| 11th Jan 2005 | 7:00 am | RNS | Clinical Trial Commences |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.